Dec 10 2013
Centro Ricerche Cliniche di Verona (CRC), a leading Early Phase Clinical Research facility, today announced that it has become the first organization to be accredited under a new scheme of quality certification conducted by EUCROF (European CROs Federation).
'We are delighted to make this announcement today confirming our successful accreditation under the EUCROF Quality Mark for Early Phase Units scheme. The system provides sponsors and study volunteers assurance that certified facilities are independently audited and have reached the highest standards of quality,' noted Stefano Milleri MD, Medical Director of CRC. 'We are sure that this Quality Mark will also provide a useful benchmark for future clients, who can now be assured instantly from an independent expert source that our work here at CRC is consistent with the highest quality and safety standards.'
'The Early Phase Unit Quality Mark accreditation scheme reflects EUCROF's commitment to continuous improvement in provision of clinical research services by our members,' said Dr. rer. nat. Susanne Gerbl-Rieger, a member of the EUCROF Early Phase Working Group. 'The audit process is independently conducted and examines 12 areas of operations which, for example, affect patient safety, regulatory compliance and organizational quality. I am pleased that CRC has been the first Early Phase Unit to be recognized with this award and look forward to other facilities joining the scheme.'
Source:
Centro Ricerche Cliniche di Verona (CRC)
New research decodes the bacterial “zip code” of colorectal cancer for prediction and survival